-
1
-
-
0018959405
-
Chemical control of ventilation and sleep arterial oxygen desaturation in patients with COPD
-
Fleetham JA, Mezon B, West P, Bradley CA, Anthonisen NR, Kryger MH. Chemical control of ventilation and sleep arterial oxygen desaturation in patients with COPD. Am Rev Respir Dis 1980;122:583-9.
-
(1980)
Am Rev Respir Dis
, vol.122
, pp. 583-589
-
-
Fleetham, J.A.1
Mezon, B.2
West, P.3
Bradley, C.A.4
Anthonisen, N.R.5
Kryger, M.H.6
-
2
-
-
0028158384
-
The relation of sleep complaints to respiratory symptoms in a general population
-
Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest 1994; 105:151-4.
-
(1994)
Chest
, vol.105
, pp. 151-154
-
-
Klink, M.E.1
Dodge, R.2
Quan, S.F.3
-
3
-
-
0041851055
-
Sleep disorders in the elderly with and without chronic airflow obstruction: The SARA study
-
Bellia V, Catalano F, Scichilone N, et al. Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 2003;26:318-23.
-
(2003)
Sleep
, vol.26
, pp. 318-323
-
-
Bellia, V.1
Catalano, F.2
Scichilone, N.3
-
4
-
-
1642447022
-
Sleep and chronic obstructive pulmonary disease
-
Kutty K. Sleep and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2004;10:104-12.
-
(2004)
Curr Opin Pulm Med
, vol.10
, pp. 104-112
-
-
Kutty, K.1
-
5
-
-
0035134410
-
Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40
-
van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, Schadé E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001;54:287-93.
-
(2001)
J Clin Epidemiol
, vol.54
, pp. 287-293
-
-
Van Manen, J.G.1
Bindels, P.J.2
IJzermans, C.J.3
Van Der Zee, J.S.4
Bottema, B.J.5
Schadé, E.6
-
6
-
-
0025248564
-
Benzodiazepines, breathing, and sleep
-
Guilleminault C. Benzodiazepines, breathing, and sleep. Am J Med 1990;88:25S-8S.
-
(1990)
Am J Med
, vol.88
, pp. 25S-8S
-
-
Guilleminault, C.1
-
7
-
-
0028840702
-
Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics
-
Vgontzas AN, Kales A, Bixler EO. Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. Pharmacology 1995;51:205-23.
-
(1995)
Pharmacology
, vol.51
, pp. 205-223
-
-
Vgontzas, A.N.1
Kales, A.2
Bixler, E.O.3
-
8
-
-
0034143762
-
Perspectives on the management of insomnia in patients with chronic respiratory disorders
-
George CF. Perspectives on the management of insomnia in patients with chronic respiratory disorders. Sleep 2000;23(Suppl. 1):S31-5.
-
(2000)
Sleep
, vol.23
, pp. S31-S35
-
-
George, C.F.1
-
9
-
-
0037287534
-
Management of insomnia in patients with chronic obstructive pulmonary disease
-
George CF, Bayliff CD. Management of insomnia in patients with chronic obstructive pulmonary disease. Drugs 2003;63:379-87.
-
(2003)
Drugs
, vol.63
, pp. 379-387
-
-
George, C.F.1
Bayliff, C.D.2
-
10
-
-
0034255401
-
The hypocretin/orexin ligand-receptor system: Implications for sleep and sleep disorders
-
Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000;23:359-65.
-
(2000)
Trends Neurosci
, vol.23
, pp. 359-365
-
-
Kilduff, T.S.1
Peyron, C.2
-
11
-
-
33846979755
-
Promotion of sleep by targeting the orexin system in rats, dogs and humans
-
Brisbare-Roch C, Dingemanse J, Koberstein R, et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007;13:150-5.
-
(2007)
Nat Med
, vol.13
, pp. 150-155
-
-
Brisbare-Roch, C.1
Dingemanse, J.2
Koberstein, R.3
-
12
-
-
33847121297
-
The neural circuit of orexin (hypocretin): Maintaining sleep and wakefulness
-
Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007;8:171-81.
-
(2007)
Nat Rev Neurosci
, vol.8
, pp. 171-181
-
-
Sakurai, T.1
-
13
-
-
24944446762
-
Hypocretins (orexins) and sleepwake disorders
-
Baumann CR, Bassetti CL. Hypocretins (orexins) and sleepwake disorders. Lancet Neurol 2005;4:673-82.
-
(2005)
Lancet Neurol
, vol.4
, pp. 673-682
-
-
Baumann, C.R.1
Bassetti, C.L.2
-
14
-
-
79951994324
-
Orexin receptors: Pharmacology and therapeutic opportunities
-
Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011; 51:243-66.
-
(2011)
Annu Rev Pharmacol Toxicol
, vol.51
, pp. 243-266
-
-
Scammell, T.E.1
Winrow, C.J.2
-
15
-
-
84876932335
-
Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders: Rationale for development and current status
-
Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status. CNS Drugs 2013;27:83-90.
-
(2013)
CNS Drugs
, vol.27
, pp. 83-90
-
-
Mieda, M.1
Sakurai, T.2
-
16
-
-
0032402181
-
Neurons containing hypocretin (orexin) project to multiple neuronal systems
-
Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
-
(1998)
J Neurosci
, vol.18
, pp. 9996-10015
-
-
Peyron, C.1
Tighe, D.K.2
Van Den Pol, A.N.3
-
17
-
-
15444371173
-
Orexin stimulates breathing via medullary and spinal pathways
-
Young JK, Wu M, Manaye KF, et al. Orexin stimulates breathing via medullary and spinal pathways. J Appl Phys 2005;98:1387-95.
-
(2005)
J Appl Phys
, vol.98
, pp. 1387-1395
-
-
Young, J.K.1
Wu, M.2
Manaye, K.F.3
-
18
-
-
53849114680
-
Orexinergic modulation of breathing across vigilance states
-
Kuwaki T. Orexinergic modulation of breathing across vigilance states. Respir Physiol Neurobiol 2008;164:204-12.
-
(2008)
Respir Physiol Neurobiol
, vol.164
, pp. 204-212
-
-
Kuwaki, T.1
-
19
-
-
53849145356
-
Hypothalamic orexins/hypocretins as regulators of breathing
-
Williams RH, Burdakov D. Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med 2008;10:e28.
-
(2008)
Expert Rev Mol Med
, vol.10
, pp. e28
-
-
Williams, R.H.1
Burdakov, D.2
-
20
-
-
84863883078
-
Respiration and autonomic regulation and orexin
-
Nattie E, Li A. Respiration and autonomic regulation and orexin. Prog Brain Res 2012;198:25-46.
-
(2012)
Prog Brain Res
, vol.198
, pp. 25-46
-
-
Nattie, E.1
Li, A.2
-
21
-
-
77954731181
-
Discovery of the dual orexin receptor antagonist[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia
-
Cox CD, Breslin MJ, Whitman DB, et al. Discovery of the dual orexin receptor antagonist[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J Med Chem 2010;53:5320-32.
-
(2010)
J Med Chem
, vol.53
, pp. 5320-5332
-
-
Cox, C.D.1
Breslin, M.J.2
Whitman, D.B.3
-
22
-
-
79956003278
-
Promotion of sleep by MK-4305 - A novel dual orexin receptor antagonist
-
Winrow CJ, Gotter AL, Cox CD, et al. Promotion of sleep by MK-4305-a novel dual orexin receptor antagonist. J Neurogenet 2011;25:52-61.
-
(2011)
J Neurogenet
, vol.25
, pp. 52-61
-
-
Winrow, C.J.1
Gotter, A.L.2
Cox, C.D.3
-
23
-
-
84871323368
-
Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
-
Herring WJ, Snyder E, Budd K, et al. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 2012;79:2265-74.
-
(2012)
Neurology
, vol.79
, pp. 2265-2274
-
-
Herring, W.J.1
Snyder, E.2
Budd, K.3
-
24
-
-
84951567173
-
Suvorexant in patients with insomnia: Results from two 3-month randomized controlled clinical trials
-
Oct 23 [Epub ahead of print]
-
Herring WJ, Connor KM, Ivgy-May N, et al. Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials. Biol Psychiatry 2014 Oct 23 [Epub ahead of print].
-
(2014)
Biol Psychiatry
-
-
Herring, W.J.1
Connor, K.M.2
Ivgy-May, N.3
-
25
-
-
84898546938
-
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: A phase 3 randomised, double-blind, placebo-controlled trial
-
Michelson D, Snyder E, Paradis E, et al. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol 2014;13:461-71.
-
(2014)
Lancet Neurol
, vol.13
, pp. 461-471
-
-
Michelson, D.1
Snyder, E.2
Paradis, E.3
-
26
-
-
84873388862
-
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men
-
Sun H, Kennedy WP, Wilbraham D, et al. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 2013;36:259-67.
-
(2013)
Sleep
, vol.36
, pp. 259-267
-
-
Sun, H.1
Kennedy, W.P.2
Wilbraham, D.3
-
28
-
-
34247475945
-
-
1st ed. Westchester, IL: American Academy of Sleep Medicine
-
Iber C, Ancoli-Israel S, Chesson AL, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
-
(2007)
The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications
-
-
Iber, C.1
Ancoli-Israel, S.2
Chesson, A.L.3
Quan, S.F.4
-
29
-
-
0003409637
-
-
National Institute of Health, APT (Association of Polysomnographic Technologists). Washington, DC: NIH Publication
-
Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subject. National Institute of Health, APT (Association of Polysomnographic Technologists). Washington, DC: NIH Publication 204; 1968.
-
(1968)
A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subject
, vol.204
-
-
Rechtschaffen, A.1
Kales, A.2
-
30
-
-
0344814079
-
L'examen clinique en psychologie
-
Paris, France: Presses Universitaires de France, Paris
-
Rey A. L'examen clinique en psychologie [Clinical tests in psychology]. Paris, France: Presses Universitaires de France, Paris; 1964.
-
(1964)
Clinical Tests in Psychology
-
-
Rey, A.1
-
31
-
-
0141687342
-
-
New York, NY: The Psychological Corporation
-
Wechsler D. WAIS-R manual. New York, NY: The Psychological Corporation; 1981.
-
(1981)
WAIS-R Manual
-
-
Wechsler, D.1
-
32
-
-
84987469571
-
The use of analogue scales in rating subjective feelings
-
Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Psychol 1974;47:211-8.
-
(1974)
Br J Psychol
, vol.47
, pp. 211-218
-
-
Bond, A.1
Lader, M.2
-
33
-
-
33645846956
-
Assessment of the AccuSwayPLUS system in measuring the effect of lorazepam on body sway in healthy volunteers
-
Norris V, Baisley K, Calder N, van Troostenburg A-R, Warrington S. Assessment of the AccuSwayPLUS system in measuring the effect of lorazepam on body sway in healthy volunteers. Int J Pharm Med 2005;19:233-8.
-
(2005)
Int J Pharm Med
, vol.19
, pp. 233-238
-
-
Norris, V.1
Baisley, K.2
Calder, N.3
Van Troostenburg, A.-R.4
Warrington, S.5
-
34
-
-
41549130564
-
Effect of ramelteon, a selective MT1/MT2-receptor agonist, on respiration during sleep in mild to moderate COPD
-
Kryger M, Wang-Weigand S, Zhang J, Roth T. Effect of ramelteon, a selective MT1/MT2-receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep Breath 2008;12:243-50.
-
(2008)
Sleep Breath
, vol.12
, pp. 243-250
-
-
Kryger, M.1
Wang-Weigand, S.2
Zhang, J.3
Roth, T.4
-
35
-
-
77956599468
-
Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1∗0602 status
-
Han F, Mignot E, Wei YC, et al. Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1∗0602 status. Eur Respir J 2010;36:577-83.
-
(2010)
Eur Respir J
, vol.36
, pp. 577-583
-
-
Han, F.1
Mignot, E.2
Wei, Y.C.3
-
36
-
-
0027222674
-
Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease
-
Steens RD, Pouliot Z, Millar TW, Kryger MH, George CF. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 1993;16:318-26.
-
(1993)
Sleep
, vol.16
, pp. 318-326
-
-
Steens, R.D.1
Pouliot, Z.2
Millar, T.W.3
Kryger, M.H.4
George, C.F.5
-
37
-
-
77349122544
-
Temazepam 10 mg does not affect breathing and gas exchange in patients with severe normocapnic COPD
-
Stege G, Heijdra YF, van den Elshout FJ, et al. Temazepam 10 mg does not affect breathing and gas exchange in patients with severe normocapnic COPD. Respir Med 2010;104:518-24.
-
(2010)
Respir Med
, vol.104
, pp. 518-524
-
-
Stege, G.1
Heijdra, Y.F.2
Van Den Elshout, F.J.3
-
38
-
-
39049113780
-
Overlap syndrome: Obstructive sleep apnea in patients with chronic obstructive pulmonary disease
-
Weitzenblum E, Chaouat A, Kessler R, Canuet M. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:237-41.
-
(2008)
Proc Am Thorac Soc
, vol.5
, pp. 237-241
-
-
Weitzenblum, E.1
Chaouat, A.2
Kessler, R.3
Canuet, M.4
-
39
-
-
0034636477
-
Prospective study of the association between sleep-disordered breathing and hypertension
-
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
-
(2000)
N Engl J Med
, vol.342
, pp. 1378-1384
-
-
Peppard, P.E.1
Young, T.2
Palta, M.3
Skatrud, J.4
-
40
-
-
4544347749
-
Sleep-disordered breathing, glucose intolerance, and insulin resistance: The sleep heart health study
-
Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am J Epidemiol 2004;160:521-30.
-
(2004)
Am J Epidemiol
, vol.160
, pp. 521-530
-
-
Punjabi, N.M.1
Shahar, E.2
Redline, S.3
Gottlieb, D.J.4
Givelber, R.5
Resnick, H.E.6
-
41
-
-
0027403440
-
One negative polysomnogram does not exclude obstructive sleep apnea
-
Meyer TJ, Eveloff SE, Kline LR, Millman RP. One negative polysomnogram does not exclude obstructive sleep apnea. Chest 1993;103:756-60.
-
(1993)
Chest
, vol.103
, pp. 756-760
-
-
Meyer, T.J.1
Eveloff, S.E.2
Kline, L.R.3
Millman, R.P.4
-
42
-
-
67649669068
-
Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography
-
Ahmadi N, Shapiro GK, Chung SA, Shapiro CM. Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography. Sleep Breath 2009;13:221-6.
-
(2009)
Sleep Breath
, vol.13
, pp. 221-226
-
-
Ahmadi, N.1
Shapiro, G.K.2
Chung, S.A.3
Shapiro, C.M.4
-
43
-
-
64149098535
-
Assessment of the test-retest reliability of laboratory polysomnography
-
Levendowski DJ, Zack N, Rao S, et al. Assessment of the test-retest reliability of laboratory polysomnography. Sleep Breath 2009;13:163-7.
-
(2009)
Sleep Breath
, vol.13
, pp. 163-167
-
-
Levendowski, D.J.1
Zack, N.2
Rao, S.3
-
44
-
-
35648987905
-
Contribution of orexin in hypercapnic chemoreflex: Evidence from genetic and pharmacological disruption and supplementation studies in mice
-
Deng BS, Nakamura A, Zhang W, Yanagisawa M, Fukuda Y, Kuwaki T. Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice. J Appl Phys 2007;103:1772-9.
-
(2007)
J Appl Phys
, vol.103
, pp. 1772-1779
-
-
Deng, B.S.1
Nakamura, A.2
Zhang, W.3
Yanagisawa, M.4
Fukuda, Y.5
Kuwaki, T.6
-
45
-
-
79251504455
-
Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle
-
Li A, Nattie E. Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. J Physiol 2010;588:2935-44.
-
(2010)
J Physiol
, vol.588
, pp. 2935-2944
-
-
Li, A.1
Nattie, E.2
-
46
-
-
43049097799
-
Sleep, hypnotics and chronic obstructive pulmonary disease
-
Stege G, Vos PJ, van den Elshout FJ, Richard Dekhuijzen PN, van de Ven MJ, Heijdra YF. Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med 2008;102:801-14.
-
(2008)
Respir Med
, vol.102
, pp. 801-814
-
-
Stege, G.1
Vos, P.J.2
Van Den Elshout, F.J.3
Richard Dekhuijzen, P.N.4
Van De Ven, M.J.5
Heijdra, Y.F.6
-
47
-
-
58149354822
-
Hypnotic use for insomnia management in chronic obstructive pulmonary disease
-
Roth T. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Sleep Med 2009;10:19-25.
-
(2009)
Sleep Med
, vol.10
, pp. 19-25
-
-
Roth, T.1
|